Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Daily Top 10 COVID-19 papers

DEU | ENG | ESP | FRA | ITA | POR | TUR | VNM


  Vaccines

  Free Subscription


Articles published in Virology

Retrieve available abstracts of 45 articles:
HTML format



Single Articles


    February 2020
  1. HUGHES LJ, Townsend MB, Gallardo-Romero N, Hutson CL, et al
    Magnitude and diversity of immune response to vaccinia virus is dependent on route of administration.
    Virology. 2020;544:55-63.
    PubMed     Abstract available


  2. PIELNAA P, Al-Saadawe M, Saro A, Dama MF, et al
    Zika virus-spread, epidemiology, genome, transmission cycle, clinical manifestation, associated challenges, vaccine and antiviral drug development.
    Virology. 2020;543:34-42.
    PubMed     Abstract available


    September 2019
  3. ZHANG C, Zheng YY, Gong YM, Zhao Z, et al
    Evaluation of immune response and protection against spring viremia of carp virus induced by a single-walled carbon nanotubes-based immersion DNA vaccine.
    Virology. 2019;537:216-225.
    PubMed     Abstract available


  4. STAUFT CB, Song Y, Gorbatsevych O, Pantoja P, et al
    Extensive genomic recoding by codon-pair deoptimization selective for mammals is a flexible tool to generate attenuated vaccine candidates for dengue virus 2.
    Virology. 2019;537:237-245.
    PubMed     Abstract available


    July 2019
  5. WANG X, Fang Z, Xiong J, Yang K, et al
    A chimpanzee adenoviral vector-based rabies vaccine protects beagle dogs from lethal rabies virus challenge.
    Virology. 2019;536:32-38.
    PubMed     Abstract available


  6. CHUONG C, Bates TA, Weger-Lucarelli J
    Infectious cDNA clones of two strains of Mayaro virus for studies on viral pathogenesis and vaccine development.
    Virology. 2019;535:227-231.
    PubMed     Abstract available


  7. KIM KH, Lee YT, Park S, Jung YJ, et al
    Neuraminidase expressing virus-like particle vaccine provides effective cross protection against influenza virus.
    Virology. 2019;535:179-188.
    PubMed     Abstract available


    June 2019
  8. MEADOR LR, Kessans SA, Kilbourne J, Kibler KV, et al
    Corrigendum to "A heterologous prime-boosting strategy with replicating Vaccinia virus vectors and plant-produced HIV-1 Gag/dgp41 virus-like particles" [Virology 507 (2017) 242-256].
    Virology. 2019 Jun 6. pii: S0042-6822(19)30139.
    PubMed    


    May 2019
  9. LEE Y, Ko EJ, Kim KH, Lee YT, et al
    A unique combination adjuvant modulates immune responses preventing vaccine-enhanced pulmonary histopathology after a single dose vaccination with fusion protein and challenge with respiratory syncytial virus.
    Virology. 2019;534:1-13.
    PubMed     Abstract available


  10. KE Y, Yu D, Zhang F, Gao J, et al
    Recombinant vesicular stomatitis virus expressing the spike protein of genotype 2b porcine epidemic diarrhea virus: A platform for vaccine development against emerging epidemic isolates.
    Virology. 2019;533:77-85.
    PubMed     Abstract available


  11. PERKINS G, Babasyan S, Stout AE, Freer H, et al
    Intranasal IgG4/7 antibody responses protect horses against equid herpesvirus-1 (EHV-1) infection including nasal virus shedding and cell-associated viremia.
    Virology. 2019;531:219-232.
    PubMed     Abstract available


    March 2019
  12. ITO H, Kanbe A, Hara A, Ishikawa T, et al
    Induction of humoral and cellular immune response to HBV vaccine can be up-regulated by STING ligand.
    Virology. 2019;531:233-239.
    PubMed     Abstract available


    January 2019
  13. LEE YT, Kim KH, Ko EJ, Kim MC, et al
    Enhancing the cross protective efficacy of live attenuated influenza virus vaccine by supplemented vaccination with M2 ectodomain virus-like particles.
    Virology. 2019;529:111-121.
    PubMed     Abstract available


  14. LIU L, Li L, Nanfack A, Mayr LM, et al
    Anti-V2 antibody deficiency in individuals infected with HIV-1 in Cameroon.
    Virology. 2019;529:57-64.
    PubMed     Abstract available


  15. LIU L, Wang T, Wang M, Tong Q, et al
    Recombinant turkey herpesvirus expressing H9 hemagglutinin providing protection against H9N2 avian influenza.
    Virology. 2019;529:7-15.
    PubMed     Abstract available


  16. YIN L, Chen L, Luo Y, Lin L, et al
    Recombinant fiber-2 protein protects Muscovy ducks against duck adenovirus 3 (DAdV-3).
    Virology. 2019;526:99-104.
    PubMed     Abstract available


    October 2018
  17. WANG SC, Liao HY, Zhang JY, Cheng TR, et al
    Development of a universal influenza vaccine using hemagglutinin stem protein produced from Pichia pastoris.
    Virology. 2018;526:125-137.
    PubMed     Abstract available


  18. QIU J, Peng S, Ma Y, Yang A, et al
    Epithelial boost enhances antigen expression by vaccinia virus for the generation of potent CD8+ T cell-mediated antitumor immunity following DNA priming vaccination.
    Virology. 2018;525:205-215.
    PubMed     Abstract available


    September 2018
  19. YAN LM, Li OTW, Poh CM, Perera RAPM, et al
    Combined use of live-attenuated and inactivated influenza vaccines to enhance heterosubtypic protection.
    Virology. 2018;525:73-82.
    PubMed     Abstract available


  20. KIM KH, Kwon YM, Lee YT, Hwang HS, et al
    Virus-like particles presenting flagellin exhibit unique adjuvant effects on eliciting T helper type 1 humoral and cellular immune responses to poor immunogenic influenza virus M2e protein vaccine.
    Virology. 2018;524:172-181.
    PubMed     Abstract available


  21. MURA M, Ruffie C, Billon-Denis E, Combredet C, et al
    hCD46 receptor is not required for measles vaccine Schwarz strain replication in vivo: Type-I IFN is the species barrier in mice.
    Virology. 2018;524:151-159.
    PubMed     Abstract available


    July 2018
  22. SHCHERBIK S, Carney P, Pearce N, Stevens J, et al
    Monoclonal antibody against N2 neuraminidase of cold adapted A/Leningrad/134/17/57 (H2N2) enables efficient generation of live attenuated influenza vaccines.
    Virology. 2018;522:65-72.
    PubMed     Abstract available


  23. CHOTHE SK, Sebastian A, Thomas A, Nissly RH, et al
    Whole-genome sequence analysis reveals unique SNP profiles to distinguish vaccine and wild-type strains of bovine herpesvirus-1 (BoHV-1).
    Virology. 2018;522:27-36.
    PubMed     Abstract available


    June 2018
  24. BODMER BS, Fiedler AH, Hanauer JRH, Prufer S, et al
    Live-attenuated bivalent measles virus-derived vaccines targeting Middle East respiratory syndrome coronavirus induce robust and multifunctional T cell responses against both viruses in an appropriate mouse model.
    Virology. 2018;521:99-107.
    PubMed     Abstract available


    May 2018
  25. LI Y, Xie L, Zhang L, Wang X, et al
    The E2 glycoprotein is necessary but not sufficient for the adaptation of classical swine fever virus lapinized vaccine C-strain to the rabbit.
    Virology. 2018;519:197-206.
    PubMed     Abstract available


  26. BOWDER D, Thompson J, Durst K, Hollingsead H, et al
    Characterization of twin-cysteine motif in the V2-loop region of gp120 in primate lentiviruses.
    Virology. 2018;519:180-189.
    PubMed     Abstract available


  27. FREY TR, Forsyth KS, Sheehan MM, De Haven BC, et al
    Ectromelia virus lacking the E3L ortholog is replication-defective and nonpathogenic but does induce protective immunity in a mouse strain susceptible to lethal mousepox.
    Virology. 2018;518:335-348.
    PubMed     Abstract available


  28. BARRIONUEVO F, Di Giacomo S, Bucafusco D, Ayude A, et al
    Systemic antibodies administered by passive immunization prevent generalization of the infection by foot-and-mouth disease virus in cattle after oronasal challenge.
    Virology. 2018;518:143-151.
    PubMed     Abstract available


    April 2018
  29. HATFIELD SD, Daniels KA, O'Donnell CL, Waggoner SN, et al
    Weak vaccinia virus-induced NK cell regulation of CD4 T cells is associated with reduced NK cell differentiation and cytolytic activity.
    Virology. 2018;519:131-144.
    PubMed     Abstract available


  30. HICKSON SE, Margineantu D, Hockenbery DM, Simon JA, et al
    Inhibition of vaccinia virus replication by nitazoxanide.
    Virology. 2018;518:398-405.
    PubMed     Abstract available


  31. KE H, Han M, Zhang Q, Rowland R, et al
    Type I interferon suppression-negative and host mRNA nuclear retention-negative mutation in nsp1beta confers attenuation of porcine reproductive and respiratory syndrome virus in pigs.
    Virology. 2018;517:177-187.
    PubMed     Abstract available


    March 2018
  32. ISAKOVA-SIVAK I, Korenkov D, Smolonogina T, Kotomina T, et al
    Broadly protective anti-hemagglutinin stalk antibodies induced by live attenuated influenza vaccine expressing chimeric hemagglutinin.
    Virology. 2018;518:313-323.
    PubMed     Abstract available


  33. MENG X, Kaever T, Yan B, Traktman P, et al
    Characterization of murine antibody responses to vaccinia virus envelope protein A14 reveals an immunodominant antigen lacking of effective neutralization targets.
    Virology. 2018;518:284-292.
    PubMed     Abstract available


  34. WANG Y, Liu R, Lu M, Yang Y, et al
    Enhancement of safety and immunogenicity of the Chinese Hu191 measles virus vaccine by alteration of the S-adenosylmethionine (SAM) binding site in the large polymerase protein.
    Virology. 2018;518:210-220.
    PubMed     Abstract available


    January 2018
  35. RODRIGUEZ L, Reedy S, Nogales A, Murcia PR, et al
    Development of a novel equine influenza virus live-attenuated vaccine.
    Virology. 2018;516:76-85.
    PubMed     Abstract available


  36. SPEAR A, Wang FX, Kappes MA, Das PB, et al
    Progress toward an enhanced vaccine: Eight marked attenuated viruses to porcine reproductive and respiratory disease virus.
    Virology. 2018;516:30-37.
    PubMed     Abstract available


    December 2017
  37. HERRERA-RODRIGUEZ J, Meijerhof T, Niesters HG, Stjernholm G, et al
    A novel peptide-based vaccine candidate with protective efficacy against influenza A in a mouse model.
    Virology. 2017;515:21-28.
    PubMed     Abstract available


  38. NICKOLS B, Tretyakova I, Tibbens A, Klyushnenkova E, et al
    Plasmid DNA launches live-attenuated Japanese encephalitis virus and elicits virus-neutralizing antibodies in BALB/c mice.
    Virology. 2017;512:66-73.
    PubMed     Abstract available


    November 2017
  39. FAKRI F, Bamouh Z, Ghzal F, Baha W, et al
    Comparative evaluation of three capripoxvirus-vectored peste des petits ruminants vaccines.
    Virology. 2017;514:211-215.
    PubMed     Abstract available


  40. HOGAN MJ, Conde-Motter A, Jordan APO, Yang L, et al
    Increased surface expression of HIV-1 envelope is associated with improved antibody response in vaccinia prime/protein boost immunization.
    Virology. 2017;514:106-117.
    PubMed     Abstract available


    October 2017
  41. DIAZ F, Gregory S, Nakashima H, Viapiano MS, et al
    Intramuscular delivery of replication-defective herpes simplex virus gives antigen expression in muscle syncytia and improved protection against pathogenic HSV-2 strains.
    Virology. 2017;513:129-135.
    PubMed     Abstract available


    September 2017
  42. GALAN-NAVARRO C, Rincon-Restrepo M, Zimmer G, Ollmann Saphire E, et al
    Oxidation-sensitive polymersomes as vaccine nanocarriers enhance humoral responses against Lassa virus envelope glycoprotein.
    Virology. 2017;512:161-171.
    PubMed     Abstract available


  43. KHUPERKAR D, Kamble A, Singh A, Ghate A, et al
    Selective recruitment of nucleoporins on vaccinia virus factories and the role of Nup358 in viral infection.
    Virology. 2017;512:151-160.
    PubMed     Abstract available


  44. HUYNH TP, Jancovich JK, Tripuraneni L, Heck MC, et al
    Characterization of a PKR inhibitor from the pathogenic ranavirus, Ambystoma tigrinum virus, using a heterologous vaccinia virus system.
    Virology. 2017 Sep 14. pii: S0042-6822(17)30275.
    PubMed     Abstract available


  45. MARTINS M, Joshi LR, Rodrigues FS, Anziliero D, et al
    Immunogenicity of ORFV-based vectors expressing the rabies virus glycoprotein in livestock species.
    Virology. 2017;511:229-239.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Vaccines is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: